{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:03:06Z","timestamp":1785250986198,"version":"3.55.0"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"29","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI110577"],"award-info":[{"award-number":["1R01AI110577"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although the SARS-CoV-2 pandemic is now largely controlled through widespread vaccination and available therapeutics, emerging variants could undermine their overall effectiveness. 4\u2032-Thiouridine (TU) and its 5\u2032-isobutyryl prodrug (iBu\u00a0TU) were identified as potent inhibitors of SARS-CoV-2 replication across various cell models, including advanced primary human respiratory models. Both compounds exhibited no significant toxicity across a range of cell culture systems, with no signs of mitochondrial damage or elevated lactic acid production. Furthermore, TU and iBu\u00a0TU tested negative for mutagenicity, aneugenic and clastogenic effects, alleviating concerns about genotoxicity. They also showed no interaction with a broad spectrum of ion channels, GPCRs, and enzymes, further confirming their favorable safety profile. TU is metabolized intracellularly to its active triphosphate form (TU-TP), which effectively disrupts viral RNA replication by acting as a delayed chain terminator. iBu\u00a0TU is rapidly converted to TU in plasma and displays superior oral bioavailability compared to TU (F = 90% vs 42% in monkeys). In a Syrian hamster model infected with SARS-CoV-2, oral iBu\u00a0TU significantly reduced viral loads (1.7 to 4.5 log10) and improved lung health without adverse effects. These findings highlight iBu\u00a0TU as a promising oral antiviral candidate for treating SARS-CoV-2 infection.<\/jats:p>","DOI":"10.1021\/acsomega.6c00102","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:27:56Z","timestamp":1783708076000},"page":"43231-43241","source":"Crossref","is-referenced-by-count":0,"title":["The 5\u2032-Isobutyryl\nEster Prodrug of 4\u2032-Thiouridine\nInhibits SARS-CoV-2 Replication in Culture and in a Syrian\nHamster Infection Model"],"prefix":"10.1021","volume":"11","author":[{"given":"Zhe","family":"Chen","sequence":"first","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6235-4050","authenticated-orcid":true,"given":"Franck","family":"Amblard","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahesh","family":"Kasthuri","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahira","family":"Tber","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"LeCher","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tao","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramyani","family":"De","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Marko","sequence":"additional","affiliation":[{"name":"University of Texas at Austin , , , ,","place":["Austin, Texas, United States, 78712"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Bassit","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keivan","family":"Zandi","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"McBrayer","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selwyn H.","family":"Hurwitz","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Weynand","sequence":"additional","affiliation":[{"name":"KU Leuven , , ,","place":["Leuven, Belgium, 3000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Abdelnabi","sequence":"additional","affiliation":[{"name":"KU Leuven , , ,","place":["Leuven, Belgium, 3000"]},{"name":"KU Leuven , , VirusBank Platform , ,","place":["Leuven, Belgium, 3000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[{"name":"KU Leuven , , ,","place":["Leuven, Belgium, 3000"]},{"name":"KU Leuven , , VirusBank Platform , ,","place":["Leuven, Belgium, 3000"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Groton, Connecticut, United States, 06340"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3624-9177","authenticated-orcid":true,"given":"Britton","family":"Boras","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["La Jolla, California, United States, 92121"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda D.","family":"Cardin","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Pearl River, New York, United States, 10965"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Pearl River, New York, United States, 10965"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mili","family":"Kapoor","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Pearl River, New York, United States, 10965"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Eng","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Groton, Connecticut, United States, 06340"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9701-756X","authenticated-orcid":true,"given":"Amit S.","family":"Kalgutkar","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siennah R.","family":"Greenfield","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhishikesh","family":"Thakare","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"King-Ahmad","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Groton, Connecticut, United States, 06340"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini C.","family":"Patel","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"University of Texas at Austin , , , ,","place":["Austin, Texas, United States, 78712"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hepworth","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8916-1895","authenticated-orcid":true,"given":"Andrew","family":"Fensome","sequence":"additional","affiliation":[{"name":"Pfizer , , , ,","place":["Cambridge, Massachusetts, United States, 02139"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-3614","authenticated-orcid":true,"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine and Children\u2019s Healthcare of Atlanta , , , ,","place":["Atlanta, Georgia, United States, 30322"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2026072810072959800_cit1","unstructured":"https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o (accessed June 17, 2026)."},{"key":"2026072810072959800_cit2","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor\nclinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"748","key":"2026072810072959800_cit3","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adj4504","article-title":"The oral nucleoside\nprodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic,\nepidemic, and enzootic coronaviruses","volume":"16","author":"Martinez","year":"2024","journal-title":"Sci. Transl.\nMed."},{"issue":"2","key":"2026072810072959800_cit4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S1473-3099(23)00577-7","article-title":"Oral VV116 versus placebo in patients with mild-to-moderate COVID-19\nin China: a multicentre, double-blind, phase 3, randomised controlled\nstudy","volume":"24","author":"Fan","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"40","key":"2026072810072959800_cit5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adz5913","article-title":"1\u2019-Cyanocytidine-5\u2032-isobutyryl\nis a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamsters","volume":"11","author":"Amblard","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"2026072810072959800_cit6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/cid\/ciae529","article-title":"Virologic Response and\nSafety of Ibuzatrelvir, A Novel SARS-CoV-2 Antiviral, in Adults With\nCOVID-19","volume":"80","author":"Mortezavi","year":"2025","journal-title":"Clin. Infect. Dis."},{"issue":"12","key":"2026072810072959800_cit7","doi-asserted-by":"publisher","first-page":"12414","DOI":"10.1021\/acs.jmedchem.4c02874","article-title":"Identification\nof 4\u2019-Thiouridine as an Orally Available Antiviral Agent Targeting\nBoth RdRp and NiRAN Functions of SARS-CoV-2 Nsp12","volume":"68","author":"Kim","year":"2025","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026072810072959800_cit8","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41392-021-00852-5","article-title":"SARS-CoV-2\nOmicron strain exhibits potent capabilities for immune evasion and\nviral entrance","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6582","key":"2026072810072959800_cit9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.abn7760","article-title":"SARS-CoV-2 Omicron variant: Antibody\nevasion and cryo-EM\nstructure of spike protein-ACE2 complex","volume":"375","author":"Mannar","year":"2022","journal-title":"Science"},{"issue":"5","key":"2026072810072959800_cit10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.cell.2022.01.019","article-title":"Structural\nand functional characterizations of infectivity and immune\nevasion of SARS-CoV-2 Omicron","volume":"185","author":"Cui","year":"2022","journal-title":"Cell"},{"issue":"4","key":"2026072810072959800_cit11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/jcc.27025","article-title":"Binding of human ACE2\nand RBD of Omicron enhanced by unique interaction\npatterns among SARS-CoV-2 variants of concern","volume":"44","author":"Kim","year":"2023","journal-title":"J. Comput. Chem."},{"issue":"1","key":"2026072810072959800_cit12","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation\nand lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat. Commun."},{"key":"2026072810072959800_cit13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41579-025-01255-x","article-title":"SARS-CoV-2 variants:\nbiology, pathogenicity, immunity and control","volume":"24","author":"Uraki","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"2026072810072959800_cit14","doi-asserted-by":"publisher","first-page":"2024.01.02.573939","DOI":"10.1101\/2024.01.02.573939","article-title":"Stably-inverted\napical-out\nhuman upper airway organoids for SARS-CoV-2 infection and therapeutic\ntesting","author":"Lee","year":"2024","journal-title":"bioRxiv"},{"issue":"1\nSuppl","key":"2026072810072959800_cit15","doi-asserted-by":"publisher","first-page":"S119","DOI":"10.1016\/j.jhep.2005.11.025","article-title":"Antiviral\nhepatitis and antiretroviral drug interactions","volume":"44","author":"Perronne","year":"2006","journal-title":"J. Hepatol."},{"issue":"4","key":"2026072810072959800_cit16","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1021\/acs.jmedchem.8b01300","article-title":"Discovery of a series\nof 2\u2019-alpha-fluoro,2\u2019-beta-bromo-ribonucleosides and\ntheir phosphoramidate prodrugs as potent pan-genotypic inhibitors\nof hepatitis C virus","volume":"62","author":"Mengshetti","year":"2019","journal-title":"J. Med. Chem."},{"issue":"5","key":"2026072810072959800_cit17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/em.22496","article-title":"A new imaging\nplatform (iScreen) allows for the concurrent assessment of micronucleus\ninduction and genotoxic mode of action in human A375 cells","volume":"63","author":"Sun","year":"2022","journal-title":"Environ. Mol. Mutagen."},{"key":"2026072810072959800_cit18","doi-asserted-by":"publisher","first-page":"100045","DOI":"10.1016\/j.crphar.2021.100045","article-title":"Comparison of anti-SARS-CoV-2 activity and\nintracellular metabolism of remdesivir and its parent nucleoside","volume":"2","author":"Tao","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"2026072810072959800_cit19","volume-title":"Kinetic Analysis for\nthe New Enzymology: Using Computer Simulation to Learn Kinetics and\nSolve Mechanisms","author":"Johnson","year":"2019"},{"issue":"1","key":"2026072810072959800_cit20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ab.2008.12.024","article-title":"Global kinetic explorer: a new computer\nprogram for dynamic simulation and fitting of kinetic data","volume":"387","author":"Johnson","year":"2009","journal-title":"Anal. Biochem."},{"issue":"12","key":"2026072810072959800_cit21","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.isci.2020.101849","article-title":"Remdesivir is effective\nin combating\nCOVID-19 because it is a better substrate than ATP for the viral RNA-dependent\nRNA polymerase","volume":"23","author":"Dangerfield","year":"2020","journal-title":"iScience"},{"issue":"30","key":"2026072810072959800_cit22","doi-asserted-by":"publisher","first-page":"10112","DOI":"10.1074\/jbc.RA120.013422","article-title":"Resistance to excision\ndetermines efficiency of hepatitis\nC virus RNA-dependent RNA polymerase inhibition by nucleotide analogs","volume":"295","author":"Villalba","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2026072810072959800_cit23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00928361","article-title":"Physiological\nconcentrations of purines and pyrimidines","volume":"140","author":"Traut","year":"1994","journal-title":"Mol.\nCell. Biochem."},{"issue":"11","key":"2026072810072959800_cit24","doi-asserted-by":"publisher","first-page":"4974","DOI":"10.1002\/jps.22674","article-title":"Development of a new\npermeability assay using low-efflux MDCKII cells","volume":"100","author":"Di","year":"2011","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"2026072810072959800_cit25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.2042-7158.1990.tb05373.x","article-title":"An improved method for the determination of distribution\ncoefficients","volume":"42","author":"Stopher","year":"1990","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"2026072810072959800_cit26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1124\/dmd.121.000801","article-title":"Disposition\nof nirmatrelvir, an orally bioavailable inhibitor of\nSARS-CoV-2 3C-like protease, across animals and humans","volume":"50","author":"Eng","year":"2022","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"2026072810072959800_cit27","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting\nclearance mechanism in drug discovery: Extended clearance classification\nsystem (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm. Res."},{"issue":"Supplement 1","key":"2026072810072959800_cit28","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/01.qai.0000137001.40505.56","article-title":"Pharmacokinetic\nproperties of nucleoside\/nucleotide reverse transcriptase inhibitors","volume":"37","author":"Piliero","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"2026072810072959800_cit29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2165\/00003088-199324020-00002","article-title":"Comparative\npharmacokinetics of antiviral\nnucleoside analogues","volume":"24","author":"Morse","year":"1993","journal-title":"Clin. Pharmacokinet."}],"container-title":["ACS Omega"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsomega.6c00102","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/29\/43231\/65878711\/acsomega.6c00102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/acsodf\/article-pdf\/11\/29\/43231\/65878711\/acsomega.6c00102.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:41:48Z","timestamp":1785249708000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/acsodf\/article\/11\/29\/43231\/5206742\/The-5-Isobutyryl-Ester-Prodrug-of-4-Thiouridine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":29,"journal-issue":{"issue":"29","published-online":{"date-parts":[[2026,7,10]]},"published-print":{"date-parts":[[2026,7,28]]}},"URL":"https:\/\/doi.org\/10.1021\/acsomega.6c00102","relation":{},"ISSN":["2470-1343"],"issn-type":[{"value":"2470-1343","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]}}}